Skip to content

Patient Perceived Outcome After Total Wrist Arthroplasty With a New Total Wrist Arthroplasty Implant

Clinical, Radiological and Patient Perceived Outcome After Total Wrist Arthroplasty With a New Total Wrist Arthroplasty Implant

Status
UNKNOWN
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02336009
Enrollment
20
Registered
2015-01-12
Start date
2014-10-31
Completion date
2019-12-31
Last updated
2018-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis, Rheumatoid Arthritis

Keywords

wrist arthritis, total wrist arthroplasty

Brief summary

Total wrist arthroplasty (TWA) surgery has developed gradually and can offer patients with rheumatoid arthritis/osteoarthritis reduced wrist pain with mainly preserved wrist range of movement. Each year 60-70 patients in Sweden are operated with a total wrist arthroplasty. Several implants are available on the market and they all have different pros and cons. One risk with a total wrist arthroplasty is loosening of the implant. If an implant is loose, revision of the implant to another TWA is sometimes possible, if not, a wrist fusion is the likely alternative. Revision rates five years after the index operation have improved, however, they cannot yet compare with the results after a total hip arthroplasty. A newly designed TWA has been developed by the department of Hand Surgery, Örebro university Hospital, Örebro, Sweden, in cooperation with Trimed Inc. The newly developed TWA offers theoretical advantages and has been biomechanically tested at the Mayo clinic. This is a pilot study where patients operated with the TWA will be assessed pre and postoperatively according to study protocol in order to evaluate outcome after TWA radiologically, clinically and regarding patient perceived outcome measures.

Detailed description

Method: Patients will be studied preoperatively and after 1, 2, 5, and 10 years with respect to changes of the following outcome measures. 1. Patient related outcome measures: DASH=Disabilities of Arm Shoulder and Hand, COPM=Canadian Occupational Performance Measure, PRWE=Patient Related Wrist Evaluation. 2. Wrist range of motion: dorsal/volar flexion, ulnar/radial deviation, pronation/supination. Hand grip strength, pinch grip, key pinch. 3. Wrist pain. VAS-pain scores (Visual analog score) at rest and in activity. 4. X-ray findings. Implant survival will be studied with Kaplan-Meyer graphs.

Interventions

DEVICEtotal wrist arthroplasty, Trimed

A new total wrist arthroplasty design. A pilot study.

Sponsors

Örebro Läns Landsting
CollaboratorOTHER_GOV
Örebro University, Sweden
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Painful wrist arthritis * Wrightington X-ray grade 2-4.

Exclusion criteria

* Infection * Substance abuse * Mental illness.

Design outcomes

Primary

MeasureTime frameDescription
revision ratechanges in revision rates up to 10 years postoperativelyThe frequency of TWA implants revised up to 10 years after the index operation

Secondary

MeasureTime frameDescription
changes in patient related outcome measures (PROM)1, 2, 5, and 10 years postoperativelyAssessed as DASH=Disabilities of Arm Shoulder and Hand, COPM=Canadian Occupational Performance Measure, PRWE=Patient Related Wrist Evaluation preoperatively and after 1, 2, 5, and 10 years postoperatively
Changes in Range of Motion (ROM1, 2, 5, and 10 years postoperativelyflexion, extension, radial and ulnar deviation, pronation, supination. Hand grip strength, pinch grip, lateral grip, and radiographic loosening, VAS-pain scores.

Countries

Sweden

Contacts

Primary ContactKurt Pettersson, MD, PhD
kurt.pettersson@orebroll.se0046196025190
Backup ContactMarcus Sagerfors, MD
marcus.sagerfors@orebroll.se0046196025507

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026